Skip to main content
Erschienen in: Urolithiasis 3/2014

01.06.2014 | Original Paper

The outcome of urine culture positive and culture negative staghorn calculi after minimally invasive percutaneous nephrolithotomy

verfasst von: Ming Lei, Wei Zhu, Shaw P. Wan, Yongda Liu, Guohua Zeng, Jian Yuan

Erschienen in: Urolithiasis | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to compare the treatment outcomes of staghorn stones using minimally invasive percutaneous nephrolithotomy (MPCNL) in patients who had positive preoperative urine culture to patients with negative urine culture. The records of 284 patients with staghorn calculi, who underwent MPCNL in our center from January 2012 to January 2013, were retrospectively analyzed. Patients were divided into positive and negative group, according to the result of preoperative urine culture. Staghorn stones with negative culture received a single dose of broad spectrum antibiotic prophylaxis, whereas stones with positive culture were treated for at least 72 h according to antibiogram. The perioperative findings and postoperative outcomes were compared between the two groups. There were 70 (24.6 %) patients with positive and 214 (75.4 %) patients with negative preoperative urine culture who underwent MPCNL. There were no statistical differences in the duration of hospital stay, operative time, estimated blood loss, final stone free rate (SFR) as well as the incidence of the following infectious complications such as fever, systemic inflammatory response syndrome and septic shock, between both groups. Our retrospective study showed that MPCNL was a safe and effective modality in the treatment of staghorn stones. The morbidity, complication, and SFR were similar between patients with positive and negative preoperative urine cultures, once the culture positive infections were adequately controlled.
Literatur
1.
Zurück zum Zitat Healy KA, Ogan K (2007) Pathophysiology and management of infectious staghorn calculi. Urol Clin North Am 34:363PubMedCrossRef Healy KA, Ogan K (2007) Pathophysiology and management of infectious staghorn calculi. Urol Clin North Am 34:363PubMedCrossRef
2.
Zurück zum Zitat Viprakasit DP, Sawyer MD, Herrell SD et al (2011) Changing composition of staghorn calculi. J Urol 186:2285PubMedCrossRef Viprakasit DP, Sawyer MD, Herrell SD et al (2011) Changing composition of staghorn calculi. J Urol 186:2285PubMedCrossRef
3.
Zurück zum Zitat Soucy F, Ko R, Duvdevani M et al (2009) Percutaneous nephrolithotomy for staghorn calculi: a single center’s experience over 15 years. J Endourol 23:1669PubMedCrossRef Soucy F, Ko R, Duvdevani M et al (2009) Percutaneous nephrolithotomy for staghorn calculi: a single center’s experience over 15 years. J Endourol 23:1669PubMedCrossRef
4.
Zurück zum Zitat Zhong W, Zeng G, Wu W et al (2011) Minimally invasive percutaneous nephrolithotomy with multiple mini tracts in a single session in treating staghorn calculi. Urol Res 39:117PubMedCrossRef Zhong W, Zeng G, Wu W et al (2011) Minimally invasive percutaneous nephrolithotomy with multiple mini tracts in a single session in treating staghorn calculi. Urol Res 39:117PubMedCrossRef
5.
Zurück zum Zitat Lojanapiwat B, Kitirattrakarn P (2011) Role of preoperative and intraoperative factors in mediating infection complication following percutaneous nephrolithotomy. Urol Int 86:448PubMedCrossRef Lojanapiwat B, Kitirattrakarn P (2011) Role of preoperative and intraoperative factors in mediating infection complication following percutaneous nephrolithotomy. Urol Int 86:448PubMedCrossRef
6.
Zurück zum Zitat El-Nahas AR, Eraky I, Shokeir AA et al (2012) Factors affecting stone-free rate and complications of percutaneous nephrolithotomy for treatment of staghorn stone. Urology 79:1236PubMedCrossRef El-Nahas AR, Eraky I, Shokeir AA et al (2012) Factors affecting stone-free rate and complications of percutaneous nephrolithotomy for treatment of staghorn stone. Urology 79:1236PubMedCrossRef
7.
Zurück zum Zitat Zeng G, Mai Z, Zhao Z et al (2013) Treatment of upper urinary calculi with Chinese minimally invasive percutaneous nephrolithotomy: a single-center experience with 12,482 consecutive patients over 20 years. Urolithiasis 41:225–229 Zeng G, Mai Z, Zhao Z et al (2013) Treatment of upper urinary calculi with Chinese minimally invasive percutaneous nephrolithotomy: a single-center experience with 12,482 consecutive patients over 20 years. Urolithiasis 41:225–229
8.
Zurück zum Zitat Labate G, Modi P, Timoney A et al (2011) The percutaneous nephrolithotomy global study: classification of complications. J Endourol 25:1275PubMedCrossRef Labate G, Modi P, Timoney A et al (2011) The percutaneous nephrolithotomy global study: classification of complications. J Endourol 25:1275PubMedCrossRef
9.
Zurück zum Zitat Wagenlehner FM, Pilatz A, Naber KG et al (2008) Therapeutic challenges of urosepsis. Eur J Clin Invest 38 Suppl 2:45PubMedCrossRef Wagenlehner FM, Pilatz A, Naber KG et al (2008) Therapeutic challenges of urosepsis. Eur J Clin Invest 38 Suppl 2:45PubMedCrossRef
10.
Zurück zum Zitat Mariappan P, Smith G, Bariol SV et al (2005) Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol 173:1610PubMedCrossRef Mariappan P, Smith G, Bariol SV et al (2005) Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol 173:1610PubMedCrossRef
11.
Zurück zum Zitat Dogan HS, Guliyev F, Cetinkaya YS et al (2007) Importance of microbiological evaluation in management of infectious complications following percutaneous nephrolithotomy. Int Urol Nephrol 39:737PubMedCrossRef Dogan HS, Guliyev F, Cetinkaya YS et al (2007) Importance of microbiological evaluation in management of infectious complications following percutaneous nephrolithotomy. Int Urol Nephrol 39:737PubMedCrossRef
12.
Zurück zum Zitat Gutierrez J, Smith A, Geavlete P et al (2013) Urinary tract infections and post-operative fever in percutaneous nephrolithotomy. World J Urol 31:1135–1140 Gutierrez J, Smith A, Geavlete P et al (2013) Urinary tract infections and post-operative fever in percutaneous nephrolithotomy. World J Urol 31:1135–1140
13.
Zurück zum Zitat Liu C, Zhang X, Liu Y, Wang P (2013) Prevention and treatment of septic shock following mini-percutaneous nephrolithotomy: a single-center retrospective study of 834 cases. World J Urol 31:1593–1597 Liu C, Zhang X, Liu Y, Wang P (2013) Prevention and treatment of septic shock following mini-percutaneous nephrolithotomy: a single-center retrospective study of 834 cases. World J Urol 31:1593–1597
14.
Zurück zum Zitat Keoghane SR, Cetti RJ, Rogers AE et al (2013) Blood transfusion, embolisation and nephrectomy after percutaneous nephrolithotomy (PCNL). BJU Int 111:628PubMedCrossRef Keoghane SR, Cetti RJ, Rogers AE et al (2013) Blood transfusion, embolisation and nephrectomy after percutaneous nephrolithotomy (PCNL). BJU Int 111:628PubMedCrossRef
15.
Zurück zum Zitat Desai M, De Lisa A, Turna B et al (2011) The clinical research office of the endourological society percutaneous nephrolithotomy global study: staghorn versus nonstaghorn stones. J Endourol 25:1263PubMedCrossRef Desai M, De Lisa A, Turna B et al (2011) The clinical research office of the endourological society percutaneous nephrolithotomy global study: staghorn versus nonstaghorn stones. J Endourol 25:1263PubMedCrossRef
16.
Zurück zum Zitat Matlaga BR, Hodges SJ, Shah OD et al (2004) Percutaneous nephrostolithotomy: predictors of length of stay. J Urol 172:1351PubMedCrossRef Matlaga BR, Hodges SJ, Shah OD et al (2004) Percutaneous nephrostolithotomy: predictors of length of stay. J Urol 172:1351PubMedCrossRef
Metadaten
Titel
The outcome of urine culture positive and culture negative staghorn calculi after minimally invasive percutaneous nephrolithotomy
verfasst von
Ming Lei
Wei Zhu
Shaw P. Wan
Yongda Liu
Guohua Zeng
Jian Yuan
Publikationsdatum
01.06.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Urolithiasis / Ausgabe 3/2014
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-014-0645-4

Weitere Artikel der Ausgabe 3/2014

Urolithiasis 3/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.